Export 238 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
J. I. Broussard, Redell, J. B., Maynard, M. E., Zhao, J., Moore, A., Mills, R. W., Hood, K. N., Underwood, E., Roysam, B., and Dash, P. K., Impaired Experience-Dependent Refinement of Place Cells in a Rat Model of Alzheimer's Disease., J Alzheimers Dis, vol. 86, no. 4, pp. 1907-1916, 2022.
L. S. Broster, Jenkins, S. L., Holmes, S. D., Jicha, G. A., and Jiang, Y., Low Arousal Positive Emotional Stimuli Attenuate Aberrant Working Memory Processing in Persons with Mild Cognitive Impairment., J Alzheimers Dis, vol. 60, no. 4, pp. 1333-1349, 2017.
N. Brosens, Samouil, D., Stolker, S., Katsika, E. Vasilina, Weggen, S., Lucassen, P. J., and Krugers, H. J., Early Life Stress Enhances Cognitive Decline and Alters Synapse Function and Interneuron Numbers in Young Male APP/PS1 Mice., J Alzheimers Dis, vol. 96, no. 3, pp. 1097-1113, 2023.
S. W. Brooks, Dykes, A. C., and Schreurs, B. G., A High-Cholesterol Diet Increases 27-Hydroxycholesterol and Modifies Estrogen Receptor Expression and Neurodegeneration in Rabbit Hippocampus., J Alzheimers Dis, vol. 56, no. 1, pp. 185-196, 2017.
K. J. Brookes, McConnell, G., Williams, K., Chaudhury, S., Madhan, G., Patel, T., Turley, C., Guetta-Baranes, T., Bras, J., Guerreiro, R., Hardy, J., Francis, P. T., and Morgan, K., Genotyping of the Alzheimer's Disease Genome-Wide Association Study Index Single Nucleotide Polymorphisms in the Brains for Dementia Research Cohort., J Alzheimers Dis, vol. 64, no. 2, pp. 355-362, 2018.
E. S. Brook, D'Alonzo, Z. J., Lam, V., Chan, D., Dhaliwal, S. Singh, Watts, G. F., Mamo, J. C. L., and Takechi, R., Plasma Amyloid-β Homeostasis Is Associated with Body Mass Index and Weight Loss in People with Overweight and Obesity., J Alzheimers Dis, vol. 93, no. 2, pp. 653-664, 2023.
M. Brody, Liu, E., Di, J., Lu, M., Margolin, R. A., Werth, J. L., Booth, K., Shadman, A., H Brashear, R., and Novak, G., A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease., J Alzheimers Dis, vol. 54, no. 4, pp. 1509-1519, 2016.
A. Brodtmann, Pemberton, H., Darby, D., and Vogel, A. P., Diagnostic Distortions: A Case Report of Progressive Apraxia of Speech., J Alzheimers Dis, vol. 53, no. 1, pp. 79-83, 2016.
D. Brici, Götz, J., and Nisbet, R. M., A Novel Antibody Targeting Tau Phosphorylated at Serine 235 Detects Neurofibrillary Tangles., J Alzheimers Dis, vol. 61, no. 3, pp. 899-905, 2018.
G. J. Brewer, Herrera, R. A., Philipp, S., Sosna, J., Reyes-Ruiz, J. Mauricio, and Glabe, C. G., Age-Related Intraneuronal Aggregation of Amyloid-β in Endosomes, Mitochondria, Autophagosomes, and Lysosomes., J Alzheimers Dis, vol. 73, no. 1, pp. 229-246, 2020.
G. J. Brewer, Divalent Copper as a Major Triggering Agent in Alzheimer's Disease., J Alzheimers Dis, 2015.
W. D. Brenowitz, Hazzouri, A. Zeki Al, Vittinghoff, E., Golden, S. H., Fitzpatrick, A. L., and Yaffe, K., Depressive Symptoms Imputed Across the Life Course Are Associated with Cognitive Impairment and Cognitive Decline., J Alzheimers Dis, vol. 83, no. 3, pp. 1379-1389, 2021.
M. Brendel, Sauerbeck, J., Greven, S., Kotz, S., Scheiwein, F., Blautzik, J., Delker, A., Pogarell, O., Ishii, K., Bartenstein, P., and Rominger, A., Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms., J Alzheimers Dis, vol. 65, no. 3, pp. 793-806, 2018.
D. E. Bredesen, Toups, K., Hathaway, A., Gordon, D., Chung, H., Raji, C., Boyd, A., Hill, B. D., Hausman-Cohen, S., Attarha, M., Chwa, W. Jong, Kurakin, A., and Jarrett, M., Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications., J Alzheimers Dis, vol. 96, no. 2, pp. 429-437, 2023.
R. H Brashear, Ketter, N., Bogert, J., Di, J., Salloway, S. P., and Sperling, R., Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies., J Alzheimers Dis, vol. 66, no. 4, pp. 1409-1424, 2018.
J. Brandt, Buchholz, A., Henry-Barron, B., Vizthum, D., Avramopoulos, D., and Cervenka, M. C., Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer's Disease., J Alzheimers Dis, vol. 68, no. 3, pp. 969-981, 2019.
C. Brandscheid, Schuck, F., Reinhardt, S., Schäfer, K. - H., Pietrzik, C. U., Grimm, M., Hartmann, T., Schwiertz, A., and Endres, K., Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model., J Alzheimers Dis, vol. 56, no. 2, pp. 775-788, 2017.
M. A. Bradley-Whitman, Abner, E., Lynn, B. C., and Lovell, M. A., A Novel Plasma Based Biomarker of Alzheimer's Disease., J Alzheimers Dis, vol. 47, no. 3, pp. 761-71, 2015.
H. Braak, Thal, D. R., Ghebremedhin, E., and Del Tredici, K., Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years., J Neuropathol Exp Neurol, vol. 70, no. 11, pp. 960-9, 2011.
W. H. Bouvy, Kuijf, H. J., Zwanenburg, J. J. M., Koek, H. L., L Kappelle, J., Luijten, P. R., M Ikram, K., and Biessels, G. Jan, Abnormalities of Cerebral Deep Medullary Veins on 7 Tesla MRI in Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease: A Pilot Study., J Alzheimers Dis, vol. 57, no. 3, pp. 705-710, 2017.
M. J. R. J. Bouts, Möller, C., Hafkemeijer, A., van Swieten, J. C., Dopper, E., van der Flier, W. M., Vrenken, H., Wink, A. Meije, Pijnenburg, Y. A. L., Scheltens, P., Barkhof, F., Schouten, T. M., de Vos, F., Feis, R. A., van der Grond, J., de Rooij, M., and Rombouts, S. A. R. B., Single Subject Classification of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Anatomical, Diffusion Tensor, and Resting-State Functional Magnetic Resonance Imaging., J Alzheimers Dis, vol. 62, no. 4, pp. 1827-1839, 2018.
C. Boutoleau-Bretonnière, Pouclet-Courtemanche, H., Gillet, A., Bernard, A., Deruet, A. Laure, Gouraud, I., Mazoue, A., Lamy, E., Rocher, L., Kapogiannis, D., and Haj, M. El, The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis., J Alzheimers Dis, vol. 76, no. 1, pp. 41-47, 2020.
O. Bousiges, Cretin, B., Lavaux, T., Philippi, N., Jung, B., Hezard, S., Heitz, C., Demuynck, C., Gabel, A., Martin-Hunyadi, C., and Blanc, F., Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies., J Alzheimers Dis, vol. 51, no. 4, pp. 1069-83, 2016.
J. Bourgin, Guyader, N., Chauvin, A., Juphard, A., Sauvée, M., Moreaud, O., Silvert, L., and Hot, P., Early Emotional Attention is Impacted in Alzheimer's Disease: An Eye-Tracking Study., J Alzheimers Dis, vol. 63, no. 4, pp. 1445-1458, 2018.
K. Bourgade, Dupuis, G., Frost, E. H., and Fülöp, T., Anti-Viral Properties of Amyloid-β Peptides., J Alzheimers Dis, vol. 54, no. 3, pp. 859-878, 2016.